NVRO Nevro Corp

Price (delayed)

$11.4

Market cap

$418.71M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.28

Enterprise value

$545.7M

Headquartered in Redwood City, California, Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. ...

Highlights
The EPS has increased by 11% since the previous quarter
NVRO's quick ratio is up by 11% since the previous quarter
The debt is up by 11% year-on-year
The equity has contracted by 8% YoY and by 5% from the previous quarter

Key stats

What are the main financial stats of NVRO
Market
Shares outstanding
36.73M
Market cap
$418.71M
Enterprise value
$545.7M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.49
Price to sales (P/S)
0.97
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.27
Earnings
Revenue
$430.75M
EBIT
-$75.27M
EBITDA
-$62.39M
Free cash flow
-$70.97M
Per share
EPS
-$2.28
Free cash flow per share
-$1.95
Book value per share
$7.65
Revenue per share
$11.81
TBVPS
$14.56
Balance sheet
Total assets
$596.05M
Total liabilities
$317.51M
Debt
$217.9M
Equity
$278.54M
Working capital
$425.83M
Liquidity
Debt to equity
0.78
Current ratio
7.38
Quick ratio
5.38
Net debt/EBITDA
-2.04
Margins
EBITDA margin
-14.5%
Gross margin
68.9%
Net margin
-19.2%
Operating margin
-22.1%
Efficiency
Return on assets
-14%
Return on equity
-28.7%
Return on invested capital
-12.4%
Return on capital employed
-14.2%
Return on sales
-17.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

NVRO stock price

How has the Nevro stock price performed over time
Intraday
2.06%
1 week
16.45%
1 month
-7.24%
1 year
-58.96%
YTD
-47.03%
QTD
-21.05%

Financial performance

How have Nevro's revenue and profit performed over time
Revenue
$430.75M
Gross profit
$296.96M
Operating income
-$95.35M
Net income
-$82.59M
Gross margin
68.9%
Net margin
-19.2%
The net margin is up by 12% since the previous quarter
The net income has grown by 10% from the previous quarter
The operating margin has grown by 6% from the previous quarter
The gross profit has grown by 5% YoY and by 2.4% from the previous quarter

Growth

What is Nevro's growth rate over time

Valuation

What is Nevro stock price valuation
P/E
N/A
P/B
1.49
P/S
0.97
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.27
The EPS has increased by 11% since the previous quarter
NVRO's P/B is 84% below its 5-year quarterly average of 9.3 and 40% below its last 4 quarters average of 2.5
The equity has contracted by 8% YoY and by 5% from the previous quarter
The P/S is 87% lower than the 5-year quarterly average of 7.2 and 43% lower than the last 4 quarters average of 1.7
The revenue has grown by 3.8% YoY

Efficiency

How efficient is Nevro business performance
The return on sales has increased by 17% since the previous quarter
The company's return on invested capital rose by 15% QoQ
The ROA has grown by 11% from the previous quarter
NVRO's return on equity is up by 9% since the previous quarter

Dividends

What is NVRO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NVRO.

Financial health

How did Nevro financials performed over time
NVRO's total assets is 88% greater than its total liabilities
Nevro's current ratio has increased by 16% QoQ and by 3.2% YoY
The total liabilities has grown by 16% YoY but it has contracted by 7% from the previous quarter
The debt is 22% smaller than the equity
The debt to equity has increased by 20% YoY and by 5% QoQ
The debt is up by 11% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.